Pump's daily trading recs, emphasis on short selling Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Pump's daily trading recs, emphasis on short selling

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Art Baeckel who wrote (5753)	10/5/2001 1:34:42 PM
From: Art Baeckel	Read Replies (1) of 6873

Advancers Lifecore Biomedical (LCBM: news, chart, profile) jumped more than 10 percent after the Chaska, Minn., firm said it has received notice that a director with the Food and Drug Administration has concurred with the recommendation for the company's Gynecare Intergel surgical adjuvant product to clear a regulatory hurdle. The company said that David Feigal has backed the FDA panel's unanimous recommendation for approval of the pre-marketing application for Gynecare, which will be used to reduce post-surgical adhesions after gynecological surgery. Lifecore said that, after finalization of labeling and the summary of safety and effectiveness, it would be able to market Gynecare in the U.S. cbs.marketwatch.com ART

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next